Mary T Szela
Director at Absci Corp (ABSI); CEO, President at TriSalus Life Sciences, Inc. (TLSI)
Purchase track record
Above average. Based on 3 purchases with a full 90 days of price history.
63
Avg. 90-day return+12.8%
vs. S&P 500+6.6%
Beat the market33%
Paper profit on buys+$39K
Total bought / sold$377K / $79K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 6SEC | ABSIAbsci Corp | Buy | 12,90021,300 held (+154%) | $11.54 | $149K | -12.0% |
| May 18SEC | TLSITriSalus Life Sciences, Inc. | Buy | 39,6821,065,215 held (+4%) | $2.59 | $103K | +56.8% |
| Mar 20SEC | TLSITriSalus Life Sciences, Inc. | Sell | 4,358768,931 held (−1%) | $4.13 | $18K | -1.7% |
| Mar 20SEC | TLSITriSalus Life Sciences, Inc. | Sell | 15,944752,987 held (−2%) | $3.85 | $61K | +5.5% |
| Feb 23SEC | TLSITriSalus Life Sciences, Inc. | Buy | 30,487773,289 held (+4%) | $4.10 | $125K | -1.0% |
- Buy
Director Mary T Szela bought $149K of ABSI at $11.54 — first open-market purchase in our records; raises the stake by 154%.
- Buy
CEO, President Mary T Szela bought $125K of TLSI at $4.10 — first open-market purchase in our records.